Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy

Journal of Controlled Release : Official Journal of the Controlled Release Society
Marina A Dobrovolskaia

Abstract

Assorted challenges in physicochemical characterization, sterilization, depyrogenation, and in the assessment of pharmacology, safety, and efficacy profiles accompany pre-clinical development of nanotechnology-formulated drugs. Some of these challenges are not unique to nanotechnology and are common in the development of other pharmaceutical products. However, nanoparticle-formulated drugs are biochemically sophisticated, which causes their translation into the clinic to be particularly complex. An understanding of both the immune compatibility of nanoformulations and their effects on hematological parameters is now recognized as an important step in the (pre)clinical development of nanomedicines. An evaluation of nanoparticle immunotoxicity is usually performed as a part of a traditional toxicological assessment; however, it often requires additional in vitro and in vivo specialized immuno- and hematotoxicity tests. Herein, I review literature examples and share the experience with the NCI Nanotechnology Characterization Laboratory assay cascade used in the early (discovery-level) phase of pre-clinical development to summarize common challenges in the immunotoxicological assessment of nanomaterials, highlight considerations an...Continue Reading

References

Sep 14, 1990·Journal of Immunological Methods·Y Aida, M J Pabst
Jan 1, 1995·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·R O CliffA S Rudolph
Jan 1, 1995·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·J SzebeniC R Alving
Aug 1, 1997·Analytical Biochemistry·P HarmonA Janoff
May 8, 1999·Pharmaceutical Development and Technology·S W Poxon, J A Hughes
Feb 3, 2000·Journal of Biotechnology·D Petsch, F B Anspach
Feb 23, 2000·The Journal of Clinical Investigation·E LienD T Golenbock
Sep 22, 2001·Toxicology in Vitro : an International Journal Published in Association with BIBRA·I LangezaalT Hartung
Jul 11, 2002·Microbes and Infection·Marina A Dobrovolskaia, Stefanie N Vogel
Apr 28, 2004·Bioelectrochemistry·D M DomańskiM Bryszewska
Jun 19, 2004·Drug Delivery·Giulio F PaciottiLawrence Tamarkin
Oct 27, 2004·Public Health Reports·Diane K Wysowski, Parivash Nourjah
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William J GradisharJoyce O'Shaughnessy
Nov 24, 2005·Journal of Endotoxin Research·Stefanie N VogelAndrei E Medvedev
May 3, 2006·Biomaterials·Arnaud VonarbourgJean-Pierre Benoit
Jun 15, 2006·Nano Letters·J M Wörle-KnirschH F Krug
Sep 13, 2006·Environmental Health Perspectives·Ken-Ichiro InoueToshikazu Yoshikawa
Jul 7, 2007·Journal of Liposome Research·János SzebeniYezheckel Barenholz
Jul 21, 2007·International Journal of Pharmaceutics·Haruna SakuraiHiroyuki Mizuguchi
Nov 1, 2007·Nature Reviews. Drug Discovery·Russell A WilkeRonald M Krauss
Nov 6, 2008·Toxicology and Applied Pharmacology·N A Monteiro-RiviereL W Zhang
Feb 17, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Evaldas SadauskasHåkan Wallin
Jun 9, 2009·Applied and Environmental Microbiology·Toru MiyamotoNoriyuki Kasai
Jul 8, 2009·Nature Nanotechnology·Marina A DobrovolskaiaJames L Weaver
Jul 9, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Valder R ArrudaJonathan D Finn
Sep 10, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marc T AbramsLaura Sepp-Lorenzino
Dec 17, 2009·The Journal of Infectious Diseases·H Shaw WarrenJean-Marc Cavaillon
Jan 2, 2010·Particle and Fibre Toxicology·Raymond F HamiltonAndrij Holian
Jan 6, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Pavan P AdiseshaiahScott E McNeil
Apr 14, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Stephan T SternScott E McNeil
Apr 15, 2010·Journal of Toxicology and Environmental Health. Part a·Yongli ShiHe Wang
Sep 30, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven K LibuttiLawrence Tamarkin
Dec 21, 2010·Nature Nanotechnology·Zhou J DengRodney F Minchin
Jan 13, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tatsuaki TagamiHiroshi Kiwada
Feb 22, 2011·TheScientificWorldJournal·Ken-Ichiro Inoue, Hirohisa Takano
Mar 25, 2011·Environmental Health and Preventive Medicine·Ken-ichiro Inoue
Jun 28, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·János SzebeniYechezkel Barenholz

❮ Previous
Next ❯

Citations

Jan 11, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Efstathios Karathanasis, Ketan B Ghaghada
Jan 8, 2016·Toxicology and Applied Pharmacology·Marina A DobrovolskaiaAnna A Shvedova
Apr 6, 2016·Regenerative Biomaterials·Richard Korsmeyer
Jun 15, 2016·Pharmaceutical Research·Daniel BoboSimon R Corrie
Jul 30, 2016·Frontiers in Immunology·Dusica Maysinger, Issan Zhang
Nov 3, 2016·Nature Reviews. Clinical Oncology·Pavan P AdiseshaiahScott E McNeil
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Saeedeh Najafi-HajivarHadi Valizadeh
Oct 19, 2016·Macromolecular Bioscience·Oleksandr ZagorodkoMaría J Vicent
Dec 22, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Edward CedroneMarina A Dobrovolskaia
Jun 21, 2018·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Blanka Halamoda-KenzaouiSusanne Bremer-Hoffmann
Aug 29, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Sijin GuoPeixuan Guo
Jan 16, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Thais Fedatto AbelhaLea Ann Dailey
Nov 18, 2017·Canadian Journal of Chemistry·Michael G Lancina, Hu Yang
Sep 27, 2018·Nanomaterials·Francesca Gatto, Giuseppe Bardi
Sep 11, 2016·The AAPS Journal·Jennifer H GrossmanJeffrey D Clogston
Oct 24, 2018·Nature Nanotechnology·Janos SzebeniMarina A Dobrovolskaia
Oct 9, 2019·Advanced Science·Gary HannonAdriele Prina-Mello
Jul 2, 2019·Advanced Functional Materials·Lauren RackleyKirill A Afonin
Dec 22, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marina A Dobrovolskaia
Mar 15, 2020·Drug Delivery and Translational Research·Maie S TahaMansoor M Amiji
Jul 6, 2018·Advanced Healthcare Materials·Zhiguo QinNing Gu
Mar 23, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Enping HongMarina A Dobrovolskaia
Jul 17, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Marina A Dobrovolskaia, Mark Bathe
Aug 4, 2020·Journal of Biomaterials Applications·Xinlu YuanAnqing Du
Aug 9, 2020·International Journal of Molecular Sciences·Christopher A W DavidNeill J Liptrott
Jul 14, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Barry W NeunMarina A Dobrovolskaia
Aug 1, 2020·Advanced Drug Delivery Reviews·Jindřich Kopeček, Jiyuan Yang
Aug 30, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Seyyed Pouya Hadipour MoghaddamHamidreza Ghandehari
Aug 26, 2019·Seminars in Cancer Biology·Sergey G KlochkovGjumrakch Aliev
Apr 4, 2020·Methods : a Companion to Methods in Enzymology·Mahmoud ElsabahyKenneth Oh
Feb 10, 2021·Allergy·Cristobalina MayorgaMaria Isabel Montañez
Dec 24, 2018·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Hannah W DespresKarina Ckless
Apr 16, 2020·Acta Biomaterialia·Waqas NawazZhiwei Wu
Aug 14, 2020·Bioconjugate Chemistry·Valentina FranciaDominik Witzigmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.